1.305
price up icon2.35%   0.03
 
loading
Evogene Ltd stock is traded at $1.305, with a volume of 16,853. It is up +2.35% in the last 24 hours and up +0.38% over the past month. Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
See More
Previous Close:
$1.275
Open:
$1.29
24h Volume:
16,853
Relative Volume:
0.01
Market Cap:
$11.56M
Revenue:
$5.64M
Net Income/Loss:
$-23.88M
P/E Ratio:
-2.4623
EPS:
-0.53
Net Cash Flow:
$-22.36M
1W Performance:
-3.33%
1M Performance:
+0.38%
6M Performance:
-7.90%
1Y Performance:
-63.24%
1-Day Range:
Value
$1.22
$1.3199
1-Week Range:
Value
$1.2036
$1.405
52-Week Range:
Value
$0.95
$3.93

Evogene Ltd Stock (EVGN) Company Profile

Name
Name
Evogene Ltd
Name
Phone
-
Name
Address
-
Name
Employee
75
Name
Twitter
@evogene_ltd
Name
Next Earnings Date
2025-08-19
Name
Latest SEC Filings
Name
EVGN's Discussions on Twitter

Compare EVGN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
EVGN
Evogene Ltd
1.305 11.56M 5.64M -23.88M -22.36M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Evogene Ltd Stock (EVGN) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-08-21 Initiated ROTH Capital Buy
Jul-29-21 Initiated Aegis Capital Buy
Dec-01-20 Initiated Cantor Fitzgerald Overweight
Dec-16-13 Initiated Oppenheimer Outperform

Evogene Ltd Stock (EVGN) Latest News

pulisher
Aug 20, 2025

Evogene Ltd (EVGN) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ... - ca.finance.yahoo.com

Aug 20, 2025
pulisher
Aug 20, 2025

Evogene Ltd. Reports Improved Revenue Amidst Losses - TipRanks

Aug 20, 2025
pulisher
Aug 19, 2025

Evogene Announces Q2 2025 Financial Results and Strategic Shift to AI - MSN

Aug 19, 2025
pulisher
Aug 19, 2025

Evogene: Q2 Earnings Snapshot - Norwalk Hour

Aug 19, 2025
pulisher
Aug 19, 2025

Evogene's Q2 2025: Unraveling Contradictions in Castor Seed Strategy and Financial Outlook - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

Evogene Q2 2025 Earnings Call Transcript - MarketBeat

Aug 19, 2025
pulisher
Aug 19, 2025

Earnings call transcript: Evogene’s Q2 2025 results reveal significant cost cuts - Investing.com

Aug 19, 2025
pulisher
Aug 19, 2025

Evogene Ltd reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 19, 2025
pulisher
Aug 19, 2025

Momentum Screeners Rank Evogene Ltd. in Top 5 TodayJuly 2025 Highlights & Proven Capital Preservation Methods - classian.co.kr

Aug 19, 2025
pulisher
Aug 19, 2025

Evogene's Earnings Dilemma: A Cautionary Tale for Biotech Innovation - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

Evogene Reports Second Quarter 2025 Financial Results - PR Newswire

Aug 19, 2025
pulisher
Aug 18, 2025

Evogene Shareholders Approve Proposals at Annual Meeting - TipRanks

Aug 18, 2025
pulisher
Aug 17, 2025

How does Evogene Ltd. correlate with Nasdaq2025 Earnings Impact & Free Safe Entry Trade Signal Reports - thegnnews.com

Aug 17, 2025
pulisher
Aug 17, 2025

Heatmap analysis for Evogene Ltd. and competitors2025 Earnings Impact & Momentum Based Trading Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Should you hold or exit Evogene Ltd. now2025 Retail Activity & Precise Swing Trade Entry Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Can Evogene Ltd. rally from current levelsJuly 2025 Recap & High Conviction Buy Zone Picks - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Evogene (EVGN) Projected to Post Quarterly Earnings on Tuesday - Defense World

Aug 17, 2025
pulisher
Aug 16, 2025

Will Evogene Ltd. see short term momentumRate Cut & High Return Trade Opportunity Guides - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Should you wait for a breakout in Evogene Ltd.Market Movement Recap & Entry Point Confirmation Signals - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Can momentum traders help lift Evogene Ltd.2025 Top Gainers & Daily Oversold Bounce Ideas - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

What MACD and RSI say about Evogene Ltd.CEO Change & Fast Momentum Stock Entry Tips - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

What risks could impact Evogene Ltd. stock performancePortfolio Growth Summary & Daily Technical Stock Forecast Reports - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Identifying reversal signals in Evogene Ltd.July 2025 Volume & Daily Growth Stock Tips - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Trend analysis for Evogene Ltd. this weekCEO Change & AI Driven Price Predictions - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Visualizing Evogene Ltd. stock with heatmapsJuly 2025 Recap & Fast Gain Swing Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Can swing trading help recover from Evogene Ltd. lossesJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

What candlestick patterns are forming on Evogene Ltd.Market Trend Summary & Reliable Entry Point Trade Alerts - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Volume spikes in Evogene Ltd. stock – what they meanJuly 2025 Opening Moves & Community Verified Watchlist Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Momentum divergence signals in Evogene Ltd. chartEarnings Risk Summary & Community Verified Watchlist Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Is Evogene Ltd. still worth holding after the dip2025 Major Catalysts & AI Powered Buy/Sell Recommendations - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Evogene Ltd. recovery potential after sell offJuly 2025 Summary & Free Safe Entry Trade Signal Reports - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Predicting Evogene Ltd. trend using moving averagesPortfolio Value Report & Free Accurate Trade Setup Notifications - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Evogene Ltd. Matches Institutional Buying FilterTrade Ideas & Fast Entry High Yield Tips - kangso.co.kr

Aug 15, 2025
pulisher
Aug 15, 2025

Evogene Ltd expected to post a loss of 45 cents a shareEarnings Preview - TradingView

Aug 15, 2025
pulisher
Aug 15, 2025

Evogene Ltd. stock daily chart insightsMarket Sentiment Review & Community Trade Idea Sharing - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Applying chart zones and confluence areas to Evogene Ltd.July 2025 Intraday Action & Safe Entry Point Alerts - Newser

Aug 15, 2025
pulisher
Aug 14, 2025

Evogene Ltd. Reaches Critical Trendline SupportJuly 2025 Macro Moves & Step-by-Step Swing Trade Plans - beatles.ru

Aug 14, 2025
pulisher
Aug 14, 2025

Evogene (NASDAQ:EVGN) Upgraded at Alliance Global Partners - Defense World

Aug 14, 2025
pulisher
Aug 13, 2025

Is Evogene Ltd. vulnerable to short sellers2025 Earnings Impact & Consistent Income Trade Ideas - thegnnews.com

Aug 13, 2025
pulisher
Aug 13, 2025

Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases - StreetInsider

Aug 13, 2025
pulisher
Aug 12, 2025

Is Evogene Ltd. likely to announce a buybackFast Money Trade Selections - 한국정경신문

Aug 12, 2025
pulisher
Aug 12, 2025

Price Consolidation Hints at Upcoming Move in Evogene Ltd.Conservative Long Term Growth Plans Under Review - sundaytimes.kr

Aug 12, 2025
pulisher
Aug 12, 2025

Evogene Ltd. and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases - MarketScreener

Aug 12, 2025
pulisher
Aug 12, 2025

Evogene partners with Tel Aviv University to develop metabolic disease treatments - Investing.com Nigeria

Aug 12, 2025
pulisher
Aug 12, 2025

Evogene partners with Tel Aviv University to develop metabolic disease treatments By Investing.com - Investing.com South Africa

Aug 12, 2025
pulisher
Aug 12, 2025

Evogene and Tel Aviv University collaborate on drug discovery for metabolite-related diseases. - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases – Company AnnouncementFT.com - Financial Times

Aug 12, 2025
pulisher
Aug 08, 2025

How Evogene Ltd. stock performs during market volatilityBuy and Hold Strategy for Capital Safety - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Can Evogene Ltd. maintain sales growthSmart Entry for Explosive Returns - mustnews.co.kr

Aug 08, 2025
pulisher
Aug 05, 2025

Has Evogene Ltd. Stock Ever Crashed Historical Volatility ReviewDownside Control Plan With Support Analysis - Newser

Aug 05, 2025
pulisher
Aug 04, 2025

Trapped Investors in Evogene Ltd. Await Breakout SignalVerified Signal From Chart Patterns Detected - beatles.ru

Aug 04, 2025

Evogene Ltd Stock (EVGN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):